Eyelash extensions may cause ocular disorders

Article

Ocular disorders such as keratoconjunctivitis and allergic blepharitis can be caused by wearing eyelash extensions.

Ocular disorders such as keratoconjunctivitis and allergic blepharitis can be caused by wearing eyelash extensions, reports a new study in the journal Cornea.

The retrospective investigation, compiled by Dr Yuki Amano and his team, Department of Ophthalmology, University of Tokyo, Graduate School of Medicine, Japan, involved 107 female patients with ocular complaints caused by eyelash extensions. Each patient had visited ophthalmologic clinics between March 2007 and March 2010. None of the patients had a history of eye disease and were aged between 21 years and 60 years.

The findings revealed that ocular disorders keratoconjunctivitis caused by invasion of glue or removing agents occurred in 64 patients. A further 42 patients experienced allergic blepharitis caused by eyelash extension glues.

Three patients presented with conjunctival erosion due to eyelid-fixing tapes, 1 patient had allergic blepharitis due to eyelid-fixing tapes and 1 patient experienced subconjunctival haemorrhage due to compression during eyelash extension removal.

Eye drops and ointments were used to treat all patients and the eyelash extension glue ingredient that caused the most ocular damage was formaldehyde.

The study suggests that the ingredients of eyelash glue should be improved, along with the ophthalmologic knowledge of physicians.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.